Skip to main content
Excell Industries Ltd. logo

Excell Industries Ltd. — Investor Relations & Filings

Ticker · EXCELINDUS ISIN · INE369A01029 LEI · 335800JQL36IBXSAGQ45 BSE.NS Manufacturing
Open in API
Filings indexed 1,107 across all filing types
Latest filing 2021-08-13 Regulatory Filings
Country IN India
Listing BSE.NS EXCELINDUS

About Excell Industries Ltd.

https://www.excelind.co.in/

Excell Industries Ltd. focuses on the production of specialty chemicals, agrochemical intermediates, and performance chemicals. The organization operates through distinct divisions dedicated to chemical manufacturing and environmental management. Its portfolio features phosphorus derivatives, polymer additives, and intermediates for the pharmaceutical sector. Beyond chemical production, the company provides integrated solutions for solid waste management, utilizing proprietary technologies for organic waste conversion and bio-remediation. The company prioritizes research and development to drive process innovation and sustainable manufacturing practices, supporting diverse applications across the agricultural, industrial, and environmental sectors.

Recent filings

Filing Released Lang Actions
Dear Sir, Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that at the meeting of the Board of Directors ....
Regulatory Filings
2021-08-13 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notice of a Board Meeting scheduled to consider and approve unaudited financial results for the quarter ended June 30, 2021. It references Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of events or information by listed companies. The document is a formal announcement informing stock exchanges and the public about the upcoming board meeting and trading window closure. It does not contain actual financial results or detailed financial data, nor is it a transcript or report. The document length is short (2685 characters) and it serves as a notification rather than a report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and disclosures that do not fit other specific categories.
2021-07-21 English
Dear Sir/ Madam, In continuation of our letter dated 30th June, 2021, for closure of trading window for the aforesaid purpose, the Trading Window for trading in Company's securities ....
Regulatory Filings Classification · 95% confidence The document is a notice of a Board Meeting scheduled to consider and approve unaudited financial results for the quarter ended June 30, 2021. It references Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures about board meetings. The document does not contain actual financial data or results but is an announcement about the upcoming board meeting and trading window closure. The document length is short (2685 characters) and serves as a notification rather than a report. Therefore, it fits the category of Regulatory Filings (RNS) as a general regulatory announcement rather than an Interim Report (IR) or Earnings Release (ER).
2021-07-21 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice of a Board Meeting scheduled to consider and approve unaudited financial results for the quarter ended June 30, 2021. It is a short announcement informing stock exchanges about the meeting date and trading window closure. It does not contain any financial data or the actual financial results report. The document length is only 2685 characters, which is quite short and consistent with an announcement rather than a full report. Therefore, this is a Regulatory Filing (RNS) as it is a general regulatory announcement about the board meeting and trading window closure, not the financial report itself.
2021-07-21 English
EXCEL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2021 ,inter alia, to consider and approve Dear Sir/ Madam, ....
Regulatory Filings Classification · 95% confidence The document is a notice of a Board Meeting scheduled to consider and approve unaudited financial results for the quarter ended June 30, 2021. It is a formal announcement sent to stock exchanges as per SEBI regulations. The document does not contain the financial results themselves, nor detailed financial data or analysis. It is a short notice informing about the upcoming board meeting and trading window closure. Therefore, it is not an Interim/Quarterly Report (IR) or Earnings Release (ER), but rather a Regulatory Filing (RNS) as it is a general regulatory announcement related to compliance and disclosure obligations.
2021-07-21 English
Updates
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming dematerialization of securities for the quarter ended 30th June 2021. It is addressed to stock exchanges and includes a confirmation from the Registrar and Transfer Agents. The document is short (2518 characters) and primarily serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for compliance certificates and miscellaneous regulatory documents.
2021-07-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.